Table 3.
Individual patients’ metabolic and histopathological responses
| Patient Number | SUV-MAX baseline | SUV-MAX week 1 | Absolute difference (ΔSUV-MAX) | Relative difference ΔSUV-MAX%)) | TRG | Presence of pCR |
|---|---|---|---|---|---|---|
| 1 |
17.6 |
12 |
−5.6 |
−31.82 |
III |
no |
| 2 * |
42 |
23 |
−19 |
−45.24 |
IV |
no |
| 3 |
21.3 |
19.4 |
−1.9 |
−8.92 |
I |
yes |
| 4 |
17 |
13 |
−4 |
−23.53 |
III |
no |
| 5 |
16.7 |
9.5 |
−7.2 |
−43.11 |
I |
yes |
| 6 |
17.8 |
13.5 |
−4.3 |
−24.16 |
III |
no |
| 7 |
13 |
18.5 |
5.5 |
42.31 |
II |
no |
| 8 |
15.2 |
15.2 |
0 |
0.00 |
II |
no |
| 9 |
20 |
13.4 |
−6.6 |
−33.00 |
IV |
no |
| 10 |
56 |
37.9 |
−18.1 |
−32.32 |
I |
yes |
| 11 |
23 |
26 |
3 |
13.04 |
III |
no |
| 12 |
28 |
36 |
8 |
28.57 |
III |
no |
| 13 |
18.2 |
15.4 |
−2.8 |
−15.38 |
III |
no |
| 14 |
16.9 |
13.7 |
−3.2 |
−18.93 |
III |
no |
| 15 |
11.9 |
9.7 |
−2.2 |
−18.49 |
IV |
no |
| 16 |
8.9 |
6.2 |
−2.7 |
−30.34 |
IV |
no |
| 17 |
7.5 |
13.9 |
6.4 |
85.33 |
IV |
no |
| 18 |
15.2 |
12.4 |
−2.8 |
−18.42 |
III |
no |
| 19 |
24.6 |
25 |
0.4 |
1.63 |
III |
no |
| 20 | 9.4 | 5.8 | −3.6 | −38.30 | I | yes |
Abbreviations: SUV-MAX - maximum standardized uptake value, pCR – pathological complete response.
*Patient was removed from per – protocol analysis because of delayed operation.